随着美国销售额的增长，Haleon利用了GL-1的副作用

2026-09-16 23:43

Haleon has seen an uptick in US sales of some of its over-the-counter products, including the pain reliever Advil and the antacid Tums, as users of GLP-1 weight-loss medications turn to the products to deal with side effects.
The consumer health company is even teaming up with stores including CVS (CVS) to have its products placed in areas frequented by weight-loss drugs patients.
"Dual placement in core aisles and GLP-1 destination sets delivers an average 24% sales lift per store," a Haleon spokesperson told Reuters, adding that items placed on designated GLP-1 shelves are outselling the same ones in stores without them.
The spokesperson added that the company has also been in discussions with Walmart (WMT) and Target (TGT).
Eli Lilly (LLY) and Novo Nordisk (NVO) are the biggest manufacturers of prescription weight-loss therapies. Lilly markets Zepbound (tirzepatide) and Foundayo (orforglipron), an oral treatment, while Novo sells Wegovy (semaglutide) and a pill version of it.

More on Haleon